Background Transforming biomarkers carry excessive potential for predicting hostile occasions in persistent coronary heart failure ( CHF ) sufferers. Nonetheless, temporal patterns throughout the course of CHF , and particularly the trajectory earlier than an hostile occasion, are unknown. We studied the prognostic worth of temporal patterns of cardiac reworking biomarker candidates in steady sufferers with CHF from the Bio-SHiFT (Serial Biomarker Measurements and New Echocardiographic Methods in Persistent Coronary heart Failure Sufferers End in Tailor-made Prediction of Prognosis) research. Strategies and Outcomes In 263 CHF sufferers, we carried out trimonthly blood sampling throughout a median follow-up of two.2 years.
For the evaluation, we chosen all baseline samples, the two samples closest to the first finish level ( PE ), or the final pattern out there for finish point-free sufferers. Thus, in 567 samples, we measured suppression of tumorigenicity-2, galectin-3, galectin-4, progress differentiation factor-15, matrix metalloproteinase-2, 3, and 9, tissue inhibitor metalloproteinase-4, perlecan, aminopeptidase-N, <em>caspase</em>-3, cathepsin-D, cathepsin-Z, and cystatin-B. The PE was a composite of cardiovascular mortality, coronary heart transplantation, left ventricular help machine implantation, and HF hospitalization. Associations between repeatedly measured biomarker candidates and the PE had been investigated by joint modeling. Median age was 68 (interquartile vary: 59-76) years with 72% males; 70 sufferers reached the PE . Repeatedly measured suppression of tumorigenicity-2, galectin-3, galectin-4, progress differentiation factor-15, matrix metalloproteinase-2 and 9, tissue inhibitor metalloproteinase-4, perlecan, cathepsin-D, and cystatin-B ranges had been considerably related to the PE , and elevated because the PE approached. The slopes of biomarker trajectories had been additionally predictors of scientific end result, impartial of their absolute stage. Associations continued after adjustment for scientific traits and pharmacological therapy.
Suppression of tumorigenicity-2 was the strongest predictor (hazard ratio: 7.55 per SD distinction, 95% CI : 5.53-10.30), adopted by progress differentiation factor-15 and matrix metalloproteinase-2. Conclusions Temporal patterns of reworking biomarker candidates predict hostile scientific outcomes in CHF. JNK and its downstream transcriptional elements together with c-Jun, activating transcription issue 2 (ATF2), and JunD had been all considerably phosphorylated in CIH rats. Nonetheless, pretreatment of NF-κB inhibitor BAY 11-7082 inhibited the activation of NF-κB below CIH situation and likewise considerably decreased the phosphorylation of JNK in addition to c-Jun, ATF2, and JunD.
Novel compound VB-037 inhibits Aβ aggregation and promotes neurite outgrowth via enhancement of HSP27 and discount of P38 and JNK-mediated irritation in cell fashions for Alzheimer’s illness.
The pathogenesis of Alzheimer’s illness (AD) is concerned within the aggregation of misfolded amyloid β (Aβ), which upregulates the exercise of acetylcholinesterase (AChE), will increase the manufacturing of reactive oxygen species (ROS), enhances neuroinflammation, and finally results in neuronal dying. Due to this fact, compounds concentrating on these mechanisms could also be candidates for multitarget medication in AD therapy. We discovered that two quinoline derivatives, VB-030 and VB-037, markedly decreased Aβ aggregation and ROS ranges within the thioflavin T biochemical assay and Tet-On Aβ-green fluorescent protein (GFP) 293 AD cell mannequin. These compounds additional improved neurite outgrowth, decreased AChE exercise and upregulated the molecular chaperone warmth shock protein household B [small] member 1 (HSP27), whereas knockdown of HSP27 counteracted the compounds’ neuroprotective results on the Tet-On neuronal mannequin. Moreover, VB-037 attenuated lipopolysaccharide (LPS)/interferon (IFN)-γ-induced activation of BV-2 microglial cells.
As well as, VB-037 demonstrated its potential to decrease LPS/IFN-γ-induced upregulation of <em>caspase</em> 1 exercise, expression of interleukin (IL)-1β, and lively phosphorylation of mitogen-activated protein kinase <em>14</em> (P38), mitogen-activated protein kinase 8 (JNK), and Jun proto-oncogene, AP-1 transcription issue subunit (JUN) signalings, in addition to enhance cell viability within the Tet-On neuronal mannequin. Our findings strongly point out the potential of VB-037 for modifying AD development by concentrating on a number of mechanisms, thereby providing a brand new drug improvement avenue for AD therapy. Hepatitis B virus X (HBx), a viral onco-protein encoded by HBV, can promote oncogenesis of HCC. Nonetheless, the mechanism of HBx in hepatocarcinogenesis remains to be unclear. On this research, we set up a brand new mouse mannequin with regular immune system to analyze the position of HBx and its purposeful mechanisms below regular immune operate.
The animal mannequin was established by injecting HBx-EGFP-<em>14</em>-19 cells into the hepatic portal vein of KM mice. To confirm the mouse mannequin, the expression of HBx within the liver tissue of mice was detected by qRT-PCR, western blotting and immunohistochemistry. The apoptosis index was calculated utilizing the terminal deoxynucleotidyl transferase-dUTP nick-end labeling (TUNEL) assay, and the expression ranges of apoptosis-related and cell cycle-related elements had been measured.
Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy by way of the Hedgehog pathway.
Research relating to macroautophagic/autophagic regulation in endothelial cells (ECs) below diabetic circumstances are very restricted. Medical proof establishes an endothelial protecting impact of metformin, however the underlying mechanisms stay unclear. We aimed to analyze whether or not metformin exerts its protecting position in opposition to hyperglycemia-induced endothelial impairment via the autophagy equipment. db/db mice had been handled with intravitreal metformin injections. Human umbilical vein endothelial cells (HUVECs) had been cultured both in regular glucose (NG, 5.5 mM) or excessive glucose (HG, 33 mM) medium within the presence or absence of metformin for 72 h. We noticed an apparent inhibition of hyperglycemia-triggered autophagosome synthesis in each the diabetic retinal vasculature and cultured HUVECs by metformin, together with restoration of hyperglycemia-impaired Hedgehog (Hh) pathway exercise.
Particularly, deletion of ATG7 in retinal vascular ECs of db/db mice and cultured HUVECs indicated a detrimental position of autophagy in hyperglycemia-induced endothelial dysfunction. Pretreatment with GANT61, a Hh pathway inhibitor, abolished the metformin-mediated downregulation of autophagy and endothelial protecting motion. Moreover, GLI-family (transcription elements of the Hh pathway) knockdown in HUVECs and retinal vasculature revealed that downregulation of hyperglycemia-activated autophagy by the metformin-mediated Hh pathway activation was GLI1 dependent. Mechanistically, GLI1 knockdown-triggered autophagy was associated to upregulation of BNIP3, which subsequently disrupted the affiliation of BECN1/Beclin 1 and BCL2.
Caspase 12 antibody |
70R-11740 |
Fitzgerald |
100 ug |
EUR 392 |
|
Description: Rabbit polyclonal Caspase 12 antibody |
Caspase 12 antibody |
70R-51166 |
Fitzgerald |
100 ul |
EUR 242 |
|
Description: Purified Polyclonal Caspase 12 antibody |
Caspase 12 antibody |
20R-1513 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 12 antibody |
Caspase 12 Antibody |
48277 |
SAB |
100ul |
EUR 429 |
Caspase 12 Antibody |
E8RT1095 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Caspase 12 Antibody |
E38PA2847 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Caspase 12 Antibody |
MBS5311249-01mg |
MyBiosource |
0.1mg |
EUR 525 |
Caspase 12 Antibody |
MBS5311249-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2325 |
Caspase 12 Antibody |
MBS5315784-01mL |
MyBiosource |
0.1mL |
EUR 470 |
Caspase 12 Antibody |
MBS5315784-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1955 |
Caspase 12 Antibody |
MBS8581604-01mL |
MyBiosource |
0.1mL |
EUR 305 |
Caspase 12 Antibody |
MBS8581604-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
Caspase 12 Antibody |
MBS8581604-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
Caspase 12 Antibody |
MBS8581604-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
Caspase 12 Antibody |
MBS8581604-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
Caspase 12 Antibody |
MBS9459373-005mL |
MyBiosource |
0.05mL |
EUR 325 |
Caspase 12 Antibody |
MBS9459373-01mL |
MyBiosource |
0.1mL |
EUR 445 |
Caspase 12 Antibody |
MBS9459373-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1860 |
Caspase 12 Antibody |
R36146-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: CASP12 |
Caspase-12 Antibody |
24119-100ul |
SAB |
100ul |
EUR 468 |
Caspase-12 Antibody |
24120-100ul |
SAB |
100ul |
EUR 468 |
Caspase-12 Antibody |
2325-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues. |
Caspase-12 Antibody |
2325-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues. |
Caspase-12 Antibody |
2327-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. |
Caspase-12 Antibody |
2327-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Caspase-12 Antibody: Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the mains, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. |
Caspase-12 Antibody |
3282-100 |
Biovision |
each |
EUR 424.8 |
Caspase-12 Antibody |
3282-30T |
Biovision |
each |
EUR 175.2 |
Caspase-12 Antibody |
E90556 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
Caspase-12 Antibody |
MBS150406-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Caspase-12 Antibody |
MBS150406-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Caspase-12 Antibody |
MBS150532-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Caspase-12 Antibody |
MBS150532-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Caspase-12 Antibody |
MBS8503096-01mL |
MyBiosource |
0.1mL |
EUR 325 |
Caspase-12 Antibody |
MBS8503096-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
Caspase-12 Antibody |
MBS8503096-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
Caspase-12 Antibody |
MBS8503096-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
Caspase-12 Antibody |
MBS8503096-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
Caspase-12 Antibody |
MBS9409151-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Caspase-12 Antibody |
MBS9409151-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Caspase-12 Antibody |
MBS9409370-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Caspase-12 Antibody |
MBS9409370-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Caspase-12 Antibody (Large) |
3195-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Caspase-12 Antibody: (Large)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues. |
Caspase-12 Antibody (Large) |
3195-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Caspase-12 Antibody: (Large)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues. |
Caspase-12 Antibody (Small) |
3197-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Caspase-12 Antibody: (Small)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues. |
Caspase-12 Antibody (Small) |
3197-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Caspase-12 Antibody: (Small)Three distinct signaling pathways lead to programmed cell death (apoptosis). The death receptor and mitochondrion pathways are the main, in which the key apoptotic proteases capase-8 and caspase-9, respectively, are involved. The endoplasmic reticulum (ER) stress is the third apoptotic pathway and caspase-12 is involved. Caspase-12 is localized to the ER but not to cytoplasm or mitochondrion. Caspase-12 is activated by ER stress, including disruption of ER calcium homeostasis, and mediates ER stress-induced apoptosis. Caspase-12 is co-localized to the ER with several proteins that are involved in Alzheimer's disease including gamma-secretase presenilin and beta-amyloid precursor protein (APP). Caspase-12 mediates cytotoxicity induced by amyloid-beta. Caspase-12 is ubiquitously expressed in mouse tissues. |
Caspase-12 Antibody (Large) |
24208-100ul |
SAB |
100ul |
EUR 468 |
Caspase-12 Antibody (Small) |
24209-100ul |
SAB |
100ul |
EUR 468 |
Caspase-12 Antibody (Small) |
MBS150848-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Caspase-12 Antibody (Small) |
MBS150848-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Caspase-12 Antibody (Large) |
MBS151444-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Caspase-12 Antibody (Large) |
MBS151444-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Caspase-12 Antibody (Large) |
MBS9401397-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Caspase-12 Antibody (Large) |
MBS9401397-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Caspase-12 Antibody (Small) |
MBS9405551-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Caspase-12 Antibody (Small) |
MBS9405551-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Rabbit anti Caspase 12 Polyclonal Antibody |
MBS460304-01mg |
MyBiosource |
0.1mg |
EUR 320 |
Rabbit anti Caspase 12 Polyclonal Antibody |
MBS460304-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1390 |
Polyclonal Caspase-12 Antibody |
APR06275G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 . This antibody is tested and proven to work in the following applications: |
Polyclonal Caspase-12 Antibody |
APR06276G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 . This antibody is tested and proven to work in the following applications: |
Polyclonal Caspase-12 Antibody |
APR00058G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 . This antibody is tested and proven to work in the following applications: |
Caspase 12 (CASP12) Antibody |
abx026563-400l |
Abbexa |
400 µl |
EUR 518.75 |
Caspase 12 (CASP12) Antibody |
abx026563-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Caspase 12 (CASP12) Antibody |
abx026563-80l |
Abbexa |
80 µl |
EUR 250 |
|
Caspase 12 (CASP12) Antibody |
abx111421-100l |
Abbexa |
100 µl |
EUR 612.5 |
Caspase 12 (CASP12) Antibody |
20-abx111421 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 12 (CASP12) Antibody |
abx129818-100l |
Abbexa |
100 µl |
EUR 262.5 |
Caspase 12 (CASP12) Antibody |
20-abx129818 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (CASP12) Antibody |
abx129818-1ml |
Abbexa |
1 ml |
EUR 687.5 |
Caspase 12 (CASP12) Antibody |
abx129818-200l |
Abbexa |
200 µl |
EUR 325 |
Caspase 12 (CASP12) Antibody |
abx100899-100l |
Abbexa |
100 µl |
EUR 262.5 |
Caspase 12 (CASP12) Antibody |
20-abx100899 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (CASP12) Antibody |
abx100899-1ml |
Abbexa |
1 ml |
EUR 725 |
Caspase 12 (CASP12) Antibody |
abx100899-200l |
Abbexa |
200 µl |
EUR 337.5 |
Caspase 12 (Casp12) Antibody |
abx318989-100l |
Abbexa |
100 µl |
EUR 250 |
Caspase 12 (Casp12) Antibody |
20-abx318989 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (Casp12) Antibody |
abx318989-50l |
Abbexa |
50 µl |
EUR 162.5 |
Caspase 12 (CASP12) Antibody |
abx318255-100g |
Abbexa |
100 µg |
EUR 362.5 |
Caspase 12 (CASP12) Antibody |
20-abx318255 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (CASP12) Antibody |
abx318255-20g |
Abbexa |
20 µg |
EUR 162.5 |
Caspase 12 (CASP12) Antibody |
abx318255-50g |
Abbexa |
50 µg |
EUR 250 |
Caspase 12 (CASP12) Antibody |
abx324638-100g |
Abbexa |
100 µg |
EUR 250 |
Caspase 12 (CASP12) Antibody |
20-abx324638 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 12 (CASP12) Antibody |
abx324638-50g |
Abbexa |
50 µg |
EUR 187.5 |
Caspase 12 (CASP12) Antibody |
abx216233-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
Caspase 12 (CASP12) Antibody |
abx213378-100g |
Abbexa |
100 µg |
EUR 250 |
Caspase 12 (CASP12) Antibody |
20-abx213378 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 12 (CASP12) Antibody |
abx231286-100g |
Abbexa |
100 µg |
EUR 350 |
Caspase 12 (CASP12) Antibody |
abx210324-100l |
Abbexa |
100 µl |
EUR 350 |
Caspase 12 (CASP12) Antibody |
20-abx210324 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Caspase 12 (CASP12) Antibody |
abx210324-50l |
Abbexa |
50 µl |
EUR 250 |
Caspase-12 polyclonal antibody |
BS3542 |
Bioworld Biotech |
50 ul |
EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
Caspase-12 Polyclonal Antibody |
BS65665 |
Bioworld Biotech |
50ul |
EUR 358 |
|
Description: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Caspase-12 Polyclonal Antibody |
E-AB-64000-120uL |
Elabscience Biotech |
120uL |
EUR 320 |
|
Description: Unconjugated |
Caspase-12 Polyclonal Antibody |
E-AB-64000-200uL |
Elabscience Biotech |
200uL |
EUR 530 |
|
Description: Unconjugated |
Caspase-12 Polyclonal Antibody |
E-AB-64000-60uL |
Elabscience Biotech |
60uL |
EUR 200 |
|
Description: Unconjugated |
Caspase-12 Polyclonal Antibody |
E-AB-64000-each |
Elabscience Biotech |
each |
Ask for price |
|
Description: Unconjugated |
Caspase-12 Polyclonal Antibody |
MBS668045-0025mg |
MyBiosource |
0.025mg |
EUR 175 |
Caspase-12 Polyclonal Antibody |
MBS668045-01mg |
MyBiosource |
0.1mg |
EUR 325 |
Caspase-12 Polyclonal Antibody |
MBS668045-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1465 |
Caspase-12 Polyclonal Antibody |
RD79981A-120uL |
Reddot Biotech |
120μL |
EUR 360 |
|
Description: Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF. |
Caspase-12 Polyclonal Antibody |
RD79981A-200uL |
Reddot Biotech |
200μL |
EUR 630 |
|
Description: Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF. |
Caspase-12 Polyclonal Antibody |
RD79981A-60uL |
Reddot Biotech |
60μL |
EUR 204 |
|
Description: Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF. |
Caspase 12 Polyclonal Antibody |
ABP50853-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of Caspase 12 from Human. This Caspase 12 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase12 |
Caspase 12 Polyclonal Antibody |
ABP50853-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of Caspase 12 from Human. This Caspase 12 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase12 |
Caspase 12 Polyclonal Antibody |
ABP50853-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of Caspase 12 from Human. This Caspase 12 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase12 |
Caspase 12 Polyclonal Antibody |
ABP50853-100uL |
Abbkine |
100 μL |
EUR 239 |
Description: Rabbit Anti-Caspase12 Polyclonal Antibody |
Caspase 12 Polyclonal Antibody |
ABP50853-200uL |
Abbkine |
200 μL |
EUR 379 |
Description: Rabbit Anti-Caspase12 Polyclonal Antibody |
Caspase 12 Polyclonal Antibody |
ABP50853-30uL |
Abbkine |
30 μL |
EUR 109 |
Description: Rabbit Anti-Caspase12 Polyclonal Antibody |
Caspase 12 polyclonal antibody |
MBS565870-01mg |
MyBiosource |
0.1mg |
EUR 520 |
Caspase 12 polyclonal antibody |
MBS565870-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2290 |
Rabbit anti-mouse Caspase-12 polyclonal Antibody(Casp12) |
MBS1498584-005mg |
MyBiosource |
0.05mg |
EUR 190 |
Rabbit anti-mouse Caspase-12 polyclonal Antibody(Casp12) |
MBS1498584-01mg |
MyBiosource |
0.1mg |
EUR 270 |
Rabbit anti-mouse Caspase-12 polyclonal Antibody(Casp12) |
MBS1498584-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
Polyclonal Caspase-12 Antibody (Large) |
APR06327G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 (Large). This antibody is tested and proven to work in the following applications: |
Polyclonal Caspase-12 Antibody (Small) |
APR06328G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-12 (Small). This antibody is tested and proven to work in the following applications: |
Caspase 12 (CASP12) Antibody (HRP) |
abx316303-100g |
Abbexa |
100 µg |
EUR 362.5 |
Caspase 12 (CASP12) Antibody (HRP) |
20-abx316303 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (CASP12) Antibody (HRP) |
abx316303-20g |
Abbexa |
20 µg |
EUR 162.5 |
Caspase 12 (CASP12) Antibody (HRP) |
abx316303-50g |
Abbexa |
50 µg |
EUR 250 |
Caspase 12 (Casp12) Antibody (HRP) |
abx318990-100l |
Abbexa |
100 µl |
EUR 250 |
Caspase 12 (Casp12) Antibody (HRP) |
20-abx318990 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (Casp12) Antibody (HRP) |
abx318990-50l |
Abbexa |
50 µl |
EUR 162.5 |
Caspase 12 (CASP12) Antibody (FITC) |
abx316304-100g |
Abbexa |
100 µg |
EUR 362.5 |
Caspase 12 (CASP12) Antibody (FITC) |
20-abx316304 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (CASP12) Antibody (FITC) |
abx316304-20g |
Abbexa |
20 µg |
EUR 162.5 |
Caspase 12 (CASP12) Antibody (FITC) |
abx316304-50g |
Abbexa |
50 µg |
EUR 250 |
Caspase 12 (Casp12) Antibody (FITC) |
abx318991-100l |
Abbexa |
100 µl |
EUR 250 |
Caspase 12 (Casp12) Antibody (FITC) |
20-abx318991 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (Casp12) Antibody (FITC) |
abx318991-50l |
Abbexa |
50 µl |
EUR 162.5 |
Rabbit Anti Caspase-12 (Aa100-116) Polyclonal Antibody |
CPBT-66303RC |
Creative Diagnostics |
0.1 mg |
EUR 540.54 |
Description: Rabbit |
Caspase 12 (CASP12) Antibody (Biotin) |
abx316305-100g |
Abbexa |
100 µg |
EUR 362.5 |
Caspase 12 (CASP12) Antibody (Biotin) |
20-abx316305 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Caspase 12 (CASP12) Antibody (Biotin) |
abx316305-20g |
Abbexa |
20 µg |
EUR 162.5 |
Caspase 12 (CASP12) Antibody (Biotin) |
abx316305-50g |
Abbexa |
50 µg |
EUR 250 |
Caspase 12 (Casp12) Antibody (Biotin) |
abx318992-100l |
Abbexa |
100 µl |
EUR 250 |
The position of BNIP3 in BECN1 dissociation from BCL2 was additional confirmed by BNIP3 overexpression or BNIP3 RNAi. Taken collectively, the endothelial protecting impact of metformin below hyperglycemia circumstances could possibly be partly attributed to its position in downregulating autophagy by way of Hh pathway activation. Abbreviations: 3-MA = 3-methyladenine; 8×GLI BS-FL = 8×GLI-binding website firefly luciferase; AAV = adeno-associated virus; AAV-Cdh5-sh-Atg7 = AAV vectors carrying shRNA in opposition to murine Atg7 below management of murine Cdh5 promoter.